Mulder M.B., Noort van M., Man de R.A., Kamar N., Bruijne de J., Knoester M., Blokzijl H., Vanwolleghem T., Roosens L., Izopet J., Gandia P., Eijk van der A.A., Metselaar H.,J., Ahsman M.J., Steeg van T.J., Hesselink D.A. and Winter de B.C.M. Development of a ribavirin dosing regimen in transplant recipients with chronic hepatitis E virus infection: a population pharmacokinetic and -dynamic model. J Antimicrob Chemother, 2025  [Link to publication].